Literature DB >> 11953391

Modulation of mouse endotoxic fever by complement.

S Li1, V M Holers, S A Boackle, C M Blatteis.   

Abstract

It was recently reported that the complement system may be critically involved in the febrile response of guinea pigs to systemic, particularly intraperitoneally (i.p.) injected, lipopolysaccharides (LPS). The present study was designed to identify which component(s) of the complement cascade may be specifically critical. To this end, we used mice with C3, C5, and CR2 gene deletions. To assess preliminarily the suitability of mice for such a study, we replicated our earlier studies with guinea pigs. Thus, to verify initially whether complement is similarly involved in the febrile response of wild-type (C57BL/6J) mice to i.p. LPS (Escherichia coli, 1 microg/mouse), we depleted complement with cobra venom factor (CVF; 7 U/mouse, intravenously [i.v.]). These animals did not develop fever, whereas the core temperature (T(c)) of CVF vehicle-treated controls rose approximately 1 degrees C by 80 min postinjection and then gradually abated over the following 2.5 h, confirming the involvement of complement in fever production after i.p. LPS injection and the suitability of this species for these studies. C3- and C5-sufficient (C3(+/+) and C5(+/+)) mice also developed 1 degrees C fevers within 80 min after i.p. LPS (1 or 2 microg/mouse) injection. These fevers were totally prevented by CVF (10 U/mouse, i.v.) pretreatment. C3- and C5-deficient (C3(-/-) and C5(-/-)) mice were also unable to develop T(c) rises after i.p. LPS. Both CR2(+/+) and CR2(-/-) mice responded normally to i.p. LPS (1 microg/mouse). These data indicate that C5, but not C3d acting through CR2, may play a critical role in the febrile response of mice to i.p. LPS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11953391      PMCID: PMC127928          DOI: 10.1128/IAI.70.5.2519-2525.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  C5a-induced hemodynamic and hematologic changes in the rabbit. Role of cyclooxygenase products and polymorphonuclear leukocytes.

Authors:  C Lundberg; F Marceau; T E Hugli
Journal:  Am J Pathol       Date:  1987-09       Impact factor: 4.307

2.  C5a-mediated release of interleukin 6 by human monocytes.

Authors:  W Scholz; M R McClurg; G J Cardenas; M Smith; D J Noonan; T E Hugli; E L Morgan
Journal:  Clin Immunol Immunopathol       Date:  1990-11

3.  Activation of the classical complement pathway in spontaneous bacterial peritonitis.

Authors:  G Bird; G Senaldi; M Panos; N Rolando; G Alexander; D Vergani; R Williams
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

4.  Recombinant C5a enhances interleukin 1 and tumor necrosis factor release by lipopolysaccharide-stimulated monocytes and macrophages.

Authors:  J M Cavaillon; C Fitting; N Haeffner-Cavaillon
Journal:  Eur J Immunol       Date:  1990-02       Impact factor: 5.532

5.  Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways.

Authors:  S J van Deventer; H R Büller; J W ten Cate; L A Aarden; C E Hack; A Sturk
Journal:  Blood       Date:  1990-12-15       Impact factor: 22.113

6.  Role of circulating endotoxin and interleukin-6 in the ACTH and corticosterone response to intraperitoneal LPS.

Authors:  M J Lenczowski; A M Van Dam; S Poole; J W Larrick; F J Tilders
Journal:  Am J Physiol       Date:  1997-12

7.  Lipopolysaccharide induces fever and depresses locomotor activity in unrestrained mice.

Authors:  W Kozak; C A Conn; M J Kluger
Journal:  Am J Physiol       Date:  1994-01

8.  Lipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane CD14.

Authors:  J A Gegner; R J Ulevitch; P S Tobias
Journal:  J Biol Chem       Date:  1995-03-10       Impact factor: 5.157

9.  Transport of bacterial lipopolysaccharide to the golgi apparatus.

Authors:  N Thieblemont; S D Wright
Journal:  J Exp Med       Date:  1999-08-16       Impact factor: 14.307

10.  The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failure.

Authors:  Z M Quezado; W D Hoffman; J A Winkelstein; I Yatsiv; C A Koev; L C Cork; R J Elin; P Q Eichacker; C Natanson
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

View more
  6 in total

1.  Mast cells are necessary for the hypothermic response to LPS-induced sepsis.

Authors:  Katherine M Nautiyal; Heather McKellar; Ann-Judith Silverman; Rae Silver
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-12-24       Impact factor: 3.619

2.  Formalin-inactivated Coxiella burnetii phase I vaccine-induced protection depends on B cells to produce protective IgM and IgG.

Authors:  Guoquan Zhang; Ying Peng; Laura Schoenlaub; Alexandra Elliott; William Mitchell; Yan Zhang
Journal:  Infect Immun       Date:  2013-04-01       Impact factor: 3.441

3.  Complement depletion renders C57BL/6 mice sensitive to the Bacillus anthracis Sterne strain.

Authors:  Eric T Harvill; Gloria Lee; Vanessa K Grippe; Tod J Merkel
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

4.  Febrile-range temperature modifies cytokine gene expression in LPS-stimulated macrophages by differentially modifying NF-{kappa}B recruitment to cytokine gene promoters.

Authors:  Zachary A Cooper; Arundhati Ghosh; Aditi Gupta; Tapan Maity; Ivor J Benjamin; Stefanie N Vogel; Jeffrey D Hasday; Ishwar S Singh
Journal:  Am J Physiol Cell Physiol       Date:  2009-10-21       Impact factor: 4.249

5.  Anamnestic protective immunity to Bacillus anthracis is antibody mediated but independent of complement and Fc receptors.

Authors:  Eric T Harvill; Manuel Osorio; Crystal L Loving; Gloria M Lee; Vanessa K Kelly; Tod J Merkel
Journal:  Infect Immun       Date:  2008-03-03       Impact factor: 3.441

Review 6.  Fever and Antipyretic Supported by Traditional Chinese Medicine: A Multi-Pathway Regulation.

Authors:  Le-Le Ma; Hui-Min Liu; Chuan-Hong Luo; Ya-Nan He; Fang Wang; Hao-Zhou Huang; Li Han; Ming Yang; Run-Chun Xu; Ding-Kun Zhang
Journal:  Front Pharmacol       Date:  2021-03-22       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.